NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
April 20, 2004 • Volume 1 / Number 16 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
SELECT Completes Randomization More than Two Years Ahead of Schedule

Director's Update
Collaboration Driving Progress in Survivorship

Cancer Research Highlights
Proteomics Shows Promise in Colon Polyp Chemoprevention Study

Aspirin Use Is Not Associated with Pancreatic Cancer Mortality, Study Reports

Study Demonstrates Limitations of Virtual Colonoscopy

Lung Cancer Disparities Between Women and Men

Special Report
Exercise Proving its Mettle Against Cancer

Conversation with Dr. Rachel Ballard-Barbash

Funding Opportunities

Featured Clinical Trial
Topical Treatment for HIV-Related Kaposi's Sarcoma

Notes
DCTD Hosts Conference

2004 Spring Research Festival at Frederick

Minority Cancer Awareness Week
New Data Support the Need to Address Cancer Disparities

Featured Meetings

Bulletin Archive

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
Funding Opportunities

The Early Detection Research Network: Biomarker Reference Laboratories

RFA-CA-05-009
Letter of Intent Receipt Date: July 16, 2004
Application Receipt Date: Aug. 16, 2004

This RFA is a reissue of RFA CA-99-008, which was published in the NIH Guide on March 16, 1999.

NCI's Division of Cancer Prevention invites new and competing renewal cooperative agreement applications to continue the Early Detection Research Network's national Biomarker Reference Laboratories, which have the responsibility for the development, evaluation, and validation of biomarkers for earlier cancer detection and risk assessment. The network has four main components: Biomarker Developmental Laboratories, Biomarker Reference Laboratories, Clinical Epidemiology and Validation Centers, and a Data Management and Coordinating Center.

This RFA will use the NIH Cooperative Agreement (U24) award mechanism.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2000.

Inquiries: Dr. Sudhir Srivastava, srivasts@mail.nih.gov; Dr. Jacob Kagan, kaganj@mail.nih.gov

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov